BioCentury | Apr 16, 2001
Finance

Ebb & Flow

U.K. investors still are willing to dole out money only in dribs and drabs, as evidenced by the recent experiences of transgenics company PPL Therapeutics and cardiac device company Aortech . Thus for the foreseeable future,...
BioCentury | Oct 16, 1995
Analyst Picks & Changes

Analyst picks & changes

...Cygnus Inc. (CYGN) Business: Diagnostics/Imaging Wheat First Butcher Singer analyst Patricia Bank raised her rating on the...
Items per page:
1 - 2 of 2
BioCentury | Apr 16, 2001
Finance

Ebb & Flow

U.K. investors still are willing to dole out money only in dribs and drabs, as evidenced by the recent experiences of transgenics company PPL Therapeutics and cardiac device company Aortech . Thus for the foreseeable future,...
BioCentury | Oct 16, 1995
Analyst Picks & Changes

Analyst picks & changes

...Cygnus Inc. (CYGN) Business: Diagnostics/Imaging Wheat First Butcher Singer analyst Patricia Bank raised her rating on the...
Items per page:
1 - 2 of 2